In this study, we validated that cancer stemness, as measured using Oct4 expression, was regulated by G9a in the temporary stemness status derived from EGFR-positive lung cancer cells, which was the EGFR-downstream protein serving as a therapeutic target. Here, POU5F1 is linked to cancer.